Close Menu

NEW YORK (GenomeWeb) – Myriad Genetics has entered into an accelerated share repurchase program with Bank of America to buy back $50 million of its common stock.

Under the terms of the agreement, Myriad will repurchase shares of its common stock discounted to the volume-weighted average share price on Nov. 16 equaling $50 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Newsweek discusses the privacy issues raised by digital medicine.

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.